Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence
NCT00435435 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 243
Last updated 2007-02-16
Summary
The aim of this study was to compare the effect of manual based cognitive therapy in adjunct of three different pharmacotherapy.
Conditions
- Alcohol Dependence
Interventions
- DRUG
-
Disulfiram
- DRUG
-
Acamprosate
- DRUG
-
Naltexone
Sponsors & Collaborators
-
Finnish Institute for Health and Welfare
lead OTHER_GOV
Principal Investigators
-
Hannu Alho, MD, PhD · National Public Health Institute, Department of Mental health and Alcohol Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-09-30
- Completion
- 2005-04-30
Countries
- Finland
Study Locations
More Related Trials
-
ED Initiated Oral Naltrexone for AUD
NCT04817410 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Nalmefene in Patients With Alcohol Dependence
NCT00811720 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Naltrexone in a Clinical Setting
NCT00000445 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Nalmefene in Patients With Alcohol Dependence
NCT00812461 ·Status: COMPLETED ·Phase: PHASE3
-
Medication Development in Alcoholism: Acamprosate Versus Naltrexone
NCT00656630 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Human Lab Model for Screening AUD Medications
NCT04249882 ·Status: COMPLETED ·Phase: PHASE2
-
Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia
NCT03479086 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers
NCT01638377 ·Status: TERMINATED ·Phase: PHASE4
-
Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling
NCT00326807 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
NCT02364947 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence
NCT02382276 ·Status: COMPLETED ·Phase: PHASE3
-
Targeted Naltrexone for Problem Drinkers
NCT00369408 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Pharmacotherapies for Alcoholism
NCT00768508 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring the PK of Different Doses of Naltrexone in Patients With AUD
NCT05919017 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
NCT04101227 ·Status: COMPLETED ·Phase: PHASE3
-
Antabuse in Severe Alcoholism: an Open Controlled Study
NCT00431262 ·Status: UNKNOWN ·Phase: PHASE4
-
Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study
NCT00769158 ·Status: COMPLETED ·Phase: PHASE1
-
In Hospital IM Naltrexone: A Pilot Study
NCT05087771 ·Status: WITHDRAWN ·Phase: PHASE4
-
Harm Reduction With Pharmacotherapy (HaRP)
NCT01932801 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking
NCT00183222 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence
NCT00811941 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Evaluation of the Empower Neuromodulation System in AUD Patients
NCT03983317 ·Status: COMPLETED ·Phase: NA
-
Post-Treatment Effects of Naltrexone
NCT00006449 ·Status: COMPLETED ·Phase: PHASE4
-
Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder
NCT05093296 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion
NCT00667771 ·Status: COMPLETED ·Phase: EARLY_PHASE1